Version 1
: Received: 3 August 2020 / Approved: 5 August 2020 / Online: 5 August 2020 (08:09:11 CEST)
How to cite:
Dittadi, R.; Afshar, H.; Carraro, P. Two SARS-CoV-2 IgG Immunoassays Comparison and Time-Course Profile of Antibodies Response. Preprints2020, 2020080114. https://doi.org/10.20944/preprints202008.0114.v1
Dittadi, R.; Afshar, H.; Carraro, P. Two SARS-CoV-2 IgG Immunoassays Comparison and Time-Course Profile of Antibodies Response. Preprints 2020, 2020080114. https://doi.org/10.20944/preprints202008.0114.v1
Dittadi, R.; Afshar, H.; Carraro, P. Two SARS-CoV-2 IgG Immunoassays Comparison and Time-Course Profile of Antibodies Response. Preprints2020, 2020080114. https://doi.org/10.20944/preprints202008.0114.v1
APA Style
Dittadi, R., Afshar, H., & Carraro, P. (2020). <strong>Two SARS-CoV-2 IgG Immunoassays Comparison and Time-Course Profile of Antibodies Response</strong>. Preprints. https://doi.org/10.20944/preprints202008.0114.v1
Chicago/Turabian Style
Dittadi, R., Haleh Afshar and Paolo Carraro. 2020 "<strong>Two SARS-CoV-2 IgG Immunoassays Comparison and Time-Course Profile of Antibodies Response</strong>" Preprints. https://doi.org/10.20944/preprints202008.0114.v1
Abstract
The role of the immune response to SARS-CoV-2 infection is not yet well known, in particular about the persistence of circulating antibodies. The aim of the study is to compare the results of two automated systems for the determination of IgG antibodies against SARS CoV-2 and to assess the time course of the IgG response after the onset of symptoms for a period longer than that evaluated to date. IgG were measured in 98 specimens of 55 subjects with COVID-19 (time from the onset of symptoms from 3 to 109 days) using the automated tests "Abbott SARS-COV-2 IgG" and the "MAGLUMI 2019-nCoV IgG". The two methods had a concordance of 91.8%, but the quantitative correlation showed very dispersed results. All the specimens resulted positive after 17 days from the onset of the synptoms. However, the median concentrations of IgG, after a rapid increase up to about 20 days, quickly decrease to about 15% of the maximum for Maglumi. The same samples measured by Architect showed a quite constant trend up to 80 day, and then an only moderate decline. The titer of IgG against SARS-CoV-2 in patients exposed to COVID-19 may significantly and rapidly decrease, with a different time-course depending on the method used for the determination.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
